Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
On a field-in-field breast tangent plan do you have a minimum MU you accept for a subfield?
Answer from: Radiation Oncologist at Community Practice
I usually avoid sub field with MU, less than 4-5 as adds little to plan quality and increases treatment time.
Sign in or Register to read more
15098
Related Questions
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
Is DCISionRT appropriate for multifocal DCIS?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?